Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-21

Clinical Trial Update: The Jordan Study for End-Stage Renal Disease Subjects [NA]

View source ↗

Summary

Alio, Inc. is recruiting participants for the Jordan Study in individuals with end-stage renal disease. The trial status is RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Alio, Inc. | Conditions: End Stage Renal Disease | NA | Status: RECRUITING